SXTC: China SXT Pharmaceuticals, Inc. - Summary | Jitta

China SXT Pharmaceuticals, Inc.

NASDAQ:SXTC

Price
$2.48
Loss Chance
58.3%
0.72JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
588 / 713
3,807 / 4,222
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (11)
Recent Business Performance (17)
Financial Strength (51)
Return to Shareholders (5)
Competitive Advantage (9)
Jitta Signs
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Key Stats
Jitta Score
Jitta Line
0.72
100.00%
3.05
215.73%
3.05
149.75%
Pharmaceuticals
4.95
54.19%
5.05
82.51%
5.69
90.01%
COMPANY DESCRIPTION
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.